Article Details

HUTCHMED Receives a US$15 million Milestone from - GlobeNewswire

Retrieved on: 2022-03-07 04:51:19

Tags for this article:

Click the tags to see associated articles and topics

HUTCHMED Receives a US$15 million Milestone from - GlobeNewswire. View article details on hiswai:

Excerpt

AstraZeneca is responsible for the commercialization of savolitinib in China and worldwide. Sales of savolitinib are recognized by AstraZeneca.

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up